Cite
HARVARD Citation
Creyns, B. et al. (n.d.). DOP26 Biological therapy increases NCR+ ILC3 levels in IBD patients. Journal of Crohn's and colitis. p. S040. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Creyns, B. et al. (n.d.). DOP26 Biological therapy increases NCR+ ILC3 levels in IBD patients. Journal of Crohn's and colitis. p. S040. [Online].